1. NEURONES reported share buybacks from October 13-17, totaling 10,489 shares. 2. The average price paid for shares was around €38.05 to €38.10. 3. Currently, NEURONES holds 0.04% of its total shares in treasury. 4. Share buyback programs often indicate confidence in company’s future. 5. Such actions can potentially support stock price stability.
Share buybacks are generally seen as a positive sign, indicating management's confidence. They may provide upward pressure on the stock price through reduced supply in the market.
The relevance of the article is high due to its direct financial implications on the stock. Share buybacks significantly impact investor sentiment and stock supply dynamics.
The effects of share buybacks can be immediate, pushing up share price shortly after the announcement or activity, based on historical market reactions.
Nanterre, October 21, 2025
Declaration of transactions on treasury shares
(period from 13 to 17 October 2025)
As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250):
| Day | Total daily volume (in number of shares) | Weighted average price (unit daily) |
| 10/16/2025 | 10,000 | €38.05 |
| 10/17/2025 | 489 | €38.10 |
| Total | 10,489 |
As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 of the 24,328,716 shares comprising the company's capital (i.e., 0.04%).
All press releases relating to the share buyback program are published in the "Regulated Information" section (under "Weekly declarations of the share buyback transactions" and "Share buyback programs") of the company's website.
About NEURONES
With over 7,250 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.
Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible
www.neurones.net
| Press Relations: O'Connection Julia Philippe-Brutin Tel.: +33 (0)6 03 63 06 03 jpbrutin@oconnection.fr | NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 rp@neurones.net | Investor Relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
Attachment
